Kneevoice is a medical technology company that developed a novel, non-invasive diagnostic platform that uses acoustic signal analysis to assess cartilage joint health in real time. By capturing and analyzing the sounds produced during joint movement, Kneevoice enables early detection, monitoring, and objective evaluation of conditions such as osteoarthritis and other degenerative joint disorders, addressing a major gap in musculoskeletal care where diagnostics are often subjective, episodic, and imaging-dependent.
Product & Technology
KneeVoice’s core product is an easy-to-use device paired with proprietary AI-driven software that records knee cartilage joint sounds and converts them into clinically actionable insights. The system provides objective, repeatable measurements that can be used in clinical settings, remote monitoring, and longitudinal tracking. This allows physicians to detect early-stage degeneration, monitor disease progression, and evaluate treatment effectiveness more efficiently than with traditional tools like X-rays or MRIs.
Business Model
KneeVoice operates on a combination of hardware and recurring software revenue. The device is sold or leased to healthcare providers, while the analytics platform is offered via a SaaS model, generating ongoing subscription revenue. Additional revenue streams may include clinical trial partnerships, data licensing, and integration with digital health platforms and electronic medical records.
Customers & Market
Primary customers include orthopedic surgeons, sports medicine physicians, primary care providers, physical therapists, and healthcare systems. Secondary markets include clinical research organizations, pharmaceutical companies conducting musculoskeletal trials, and eventually direct-to-consumer applications for at-home monitoring. Kneevoice is positioned within the rapidly growing digital health and orthopedic diagnostics market, driven by aging populations and increasing prevalence of joint disease.
Traction & Clinical Strategy
The company is actively pursuing clinical validation and regulatory pathways, including FDA 510k Clearance already granted, Pilot programs and collaborations with leading orthopedic institutions are underway to validate accuracy, usability, and clinical utility.
Team & Credentials
KneeVoice is led by a team with deep expertise in medical technology, orthopedics, and business development, supported by experienced advisors and investors from the MedTech ecosystem. The company has backing from recognized angel groups and private investors, along with strategic guidance from industry veterans with experience in scaling orthopedic and diagnostic technologies.
Ready to Ask For Funding for your company?
Post a Funding Request